Skip to main content
GENINUS Inc. logo

GENINUS Inc. — Investor Relations & Filings

Ticker · 389030 ISIN · KR7389030008 KO Professional, scientific and technical activities
Open in API
Filings indexed 160 across all filing types
Latest filing 2021-11-12 Major Shareholding Noti…
Country KR South Korea
Listing KO 389030

About GENINUS Inc.

https://www.kr-geninus.com/

GENINUS Inc. is a biotechnology company specializing in genomic and multi-omics analysis for precision medicine. The company provides comprehensive solutions for drug development, diagnostics, and clinical research, with a focus on single-cell analysis, cancer genome companion diagnostics, and AI-driven biomarker discovery. Its proprietary platforms include IntelliMed™ for clinical genomics, MEDINSIGHT™ for AI-powered digital pathology, and SPACEINSIGHT™, a cloud-based platform for spatial multi-omics data analysis. By integrating advanced analytics with artificial intelligence, GENINUS delivers genetic insights to support personalized treatment strategies, disease prevention, and the development of novel therapeutics.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required when an entity or individual acquires a significant stake (typically 5% or more) in a publicly traded company. In the provided taxonomy, this corresponds to a 'Major Shareholding Notification' (MRQ).
2021-11-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is used to disclose changes in shareholdings by major shareholders or insiders. In the provided taxonomy, 'Major Shareholding Notification' (MRQ) is the most appropriate category for disclosures regarding significant share ownership levels and changes therein.
2021-11-12 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the acquisition of shares by 'Company K Partners' in 'Geninus Co., Ltd.' and lists the reporting entity, special relations, and the number of shares held. This falls under the category of Major Shareholding Notification.
2021-11-08 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. This document details the final results of a public offering, including subscription and allocation data for institutional and retail investors. It is a standard regulatory filing related to capital changes and share issuance. Since it is a formal report of the issuance results rather than an announcement of a report, it falls under the category of share issuance/capital change filings.
2021-11-01 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서(지분증권) 정정신고서' (Securities Registration Statement Amendment) filed with the Financial Services Commission (금융위원회) in South Korea. It details the finalization of the public offering price (공모가액 확정) for Geninus Co., Ltd. and provides updated information regarding the offering terms, allocation, and underwriting details. This type of filing is a regulatory document related to capital raising and share issuance, which falls under the 'Share Issue/Capital Change' category.
2021-10-26 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a '정정신고(보고)' (Amendment Report) for an '투자설명서' (Prospectus) filed by Geninus Inc. It details changes to the offering price, total offering amount, and allocation ratios following the determination of the final public offering price. This is a formal regulatory filing related to a securities offering (IPO) and does not fit into categories like Annual Reports, Earnings Releases, or Call Transcripts. It is a standard regulatory document for securities registration and amendment.
2021-10-26 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.